mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.1 |